What letting RFK Jr. 'go wild' might mean for Trump's FDA
With Donald Trump’s victory in the presidential election, public health experts are anxiously waiting to see whether his embrace of Robert F. Kennedy Jr. will translate into real policy, and perhaps chaos, at the Food and Drug Administration — the regulator tasked with ensuring that America’s drugs are effective and its food is safe to eat.
In the weeks leading up to the election, Trump promised supporters that he would give RFK Jr. an important role in his administration and let him “go wild” on health care.
In his victory speech, the president-elect name-checked Kennedy again. “He’s going to help make America healthy again,” Trump said. “He’s a great guy and he really means it. He wants to do some things, and we’re gonna let him go to it.”
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
View All Plans
To read the rest of this story subscribe to STAT+.
Subscribe
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter.
